BackCERo Therapeutics Holdings Overview

CERo Therapeutics Holdings Other Income Expense Net

Other Income/Expense Net for CERO.

Quarterly Other Income/Expense

-$1.04M
↓ 569.36% YoY

As of Mar 31, 2026

Annual Other Income/Expense (TTM)

-$84.60M
↓ 3232.1% YoY

Trailing 12 months ending Mar 31, 2026

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin